Bruker (BRKR) Free Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.50% |
| Dec 31, 2025 | 3.53% |
| Sep 30, 2025 | -23.17% |
| Jun 30, 2025 | -77.27% |
| Mar 31, 2025 | 54.02% |
| Dec 31, 2024 | 7.26% |
| Sep 30, 2024 | -30.67% |
| Jun 30, 2024 | -26.00% |
| Mar 31, 2024 | -35.56% |
| Dec 31, 2023 | 9.21% |
| Sep 30, 2023 | 1.33% |
| Jun 30, 2023 | -19.01% |
| Mar 31, 2023 | 12.10% |
| Dec 31, 2022 | 8.44% |
| Sep 30, 2022 | -14.01% |
| Jun 30, 2022 | -18.38% |
| Mar 31, 2022 | 22.75% |
| Dec 31, 2021 | 6.70% |
| Sep 30, 2021 | -22.45% |
| Jun 30, 2021 | -15.76% |
| Mar 31, 2021 | 39.76% |
| Dec 31, 2020 | 4.74% |
| Sep 30, 2020 | 7.71% |
| Jun 30, 2020 | 1.57% |
| Mar 31, 2020 | -26.72% |
| Dec 31, 2019 | 11.67% |
| Sep 30, 2019 | 58.67% |
| Jun 30, 2019 | -27.51% |
| Mar 31, 2019 | -17.29% |
| Dec 31, 2018 | -1.76% |
| Sep 30, 2018 | -10.67% |
| Jun 30, 2018 | 25.94% |
| Mar 31, 2018 | 25.20% |
| Dec 31, 2017 | 6.10% |
| Sep 30, 2017 | 27.08% |
| Jun 30, 2017 | -28.21% |
| Mar 31, 2017 | 38.54% |
| Dec 31, 2016 | 1.61% |
| Sep 30, 2016 | 19.33% |
| Jun 30, 2016 | 19.71% |
| Mar 31, 2016 | 10.96% |
| Dec 31, 2015 | 11.00% |
| Sep 30, 2015 | 195.55% |
| Jun 30, 2015 | -17.27% |
| Mar 31, 2015 | 192.20% |